Tag: psoriatic arthritis
Sun Pharma announces US FDA acceptance of sBLA application for ILUMYA...
If the sBLA is approved, expansion into psoriatic arthritis would build on the established clinical experience of ILUMYA as an IL-23 inhibitor for moderate-to-severe plaque psoriasis; FDA decision expected by October 29, 2026
Eli Lilly forays into dermatological space, launches psoriasis drug Copellor in...
Post approval from the Drugs Controller General of India, the drug will be available for treatment of adults with moderate-to-severe plaque psoriasis
Janssen launches icare4u program for disorders caused by excessive inflammation
Research shows that people living with inflammatory disorders are at increased risk of depression and anxiety, with those most affected also experiencing worse disease activity